Image
02.08.2022
New Continuous Glucose Monitor available on prescription today
We welcome the addition of a new CGM device to promote greater choice for people with diabetes.
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more